GlaxoSmithKline breathes easier as U.S. approves triple lung drug | Reuters
FDA OKs Glaxo's inhaler, first one to combine 3 medicines | The Seattle Times
GSK's 3-drug inhaler for asthma patients wins US nod | Deccan Herald
GSK's 3-in-1 inhaler for COPD arrives in Korea < Pharma < Article - KBR
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting
Wirkstoffkombination für COPD-Patienten: Erstattungsbetrag für Anoro vereinbart
GSK launches once daily, single inhaler-triple therapy for COPD patients for the first time in India
Initiation of single-inhaler COPD triple therapy improved adherence vs. multiple inhalers
GSK expands its portfolio of medicines in the US for patients with asthma and COPD
GSK launches single inhaler-triple therapy Trelegy Ellipta to treat COPD in India
GSK launches once daily, single inhaler-triple therapy for COPD patients - BioVoiceNews
Die BREO Ellipta dosierte Asthma Inhalator, hergestellt von GlaxoSmithKline, ist abgebildet auf Weiß. Die aktiven Inhaltsstoffe in Breo sind Fluticason und vilanterol Stockfotografie - Alamy
COPD: GSK launches once daily, single inhaler-triple therapy for COPD patients - The Economic Times
GSK seeks additional asthma indication for Trelegy Ellipta - MassDevice
Propeller Health Announces Expansion of Digital Health Collaboration with GlaxoSmithKline to Improve Management of Asthma and COPD - Propeller Health
It's make-or-break time for GSK's new sales model as Anoro hits the U.S. market | Fierce Pharma
GSK files triple combo for COPD in Europe - PharmaTimes
GSK opens £56m Ellipta inhaler plant in the UK
GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media
CHONBURI, THAILAND-JANUARY 31, 2021 : Symbicort, Avamys, Seretide, Ventolin, with Tablets Pills and Bottle on Blue Background. Editorial Image - Image of seretide, budesonide: 209255395
GSK's Arnuity and Incruse Ellipta Available in US for Asthma and COPD Patients | RT
COPD inhaler – Bild kaufen – 11727929 ❘ Science Photo Library
Theravance and GSK launch Breo Ellipta in USA
Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose - RightBreathe
Allergy & Asthma Network on Twitter: "New @GSK IMPACT (Informing Pathway of COPD Treatment) Study on new FDA-approved inhaler Trelegy Ellipta: https://t.co/i40i70n9f4 https://t.co/GJukAOQ7Tr" / Twitter
